MADISON, Wis. - In a teleconference on Tuesday, Wisconsin's Controlled Substances Board passed an order to schedule the drug Epidiolex and any similar drugs containing cannabidiol approved by the U.S. Food and Drug Administration as a schedule V controlled substance.
Epidiolex is a medication containing CBD, a component of cannabis, approved to treat seizures.
It was the first drug with CBD approved by the FDA.
Top Image: © Herreid | Adobe Stock
